论文部分内容阅读
Objective To study the pharmacokinetics of intravenous magnesium isoglycyrrhizinate injection in health volunteers with HPLC-UV. Methods Single doses of 200mg magnesium isoglycyrrhizinate were administrated to 10 health volunteers by i.v. infusion. The concentrations of magnesium isoglycyrrhizinate in plasma were assayed by HPLC-UV method. The pharmacokinetic parameters of magnesium isoglycyrrhizinate injection were calculated by program 3P87. Results The main pharmacokinetic parameters of intravenous magnesium isoglycyrrhizinate were as follows: c_ max (67.58±8.84) mg/L, T_ 1/2α (1.46±0.35) h, T_ 1/2β (23.95±4.72) h, V_ d (2.921±0.382) L, CL (0.186±0.048) L/h,k_ 10 (0.064±0.016) h~ -1 , AUC_ 0-T (1015.29±225.14) mg·h~ -1 ·L~ -1 ,respectively. Conclusion We have successfully used the analytical method for magnesium isoglycyrrhizinate to study its pharmacokinetical properties of health volunteers after i.v. infusion. The method is found to be simple, accurate, stable and sensitive for application in clinical pharmacokinetics study. The concentration-time plot was fitted to a two-compartment open model with first-order elimination.
Objective To study the pharmacokinetics of intravenous magnesium isoglycyrrhizinate injection in health volunteers with HPLC-UV. Methods Single doses of 200 mg magnesium isoglycyrrhizinate were administered to 10 health volunteers by iv infusion. The concentrations of magnesium isoglycyrrhizinate in plasma were assayed by HPLC-UV method. The pharmacokinetic parameters of magnesium isoglycyrrhizinate injection were calculated by program 3P87. Results The main pharmacokinetic parameters of intravenous magnesium isoglycyrrhizinate were as follows: c_max (67.58 ± 8.84) mg / L, T_1 / 2α (1.46 ± 0.35) h, T_1 / 2β (23.95 ± 4.72) h, V_d (2.921 ± 0.382) L, CL (0.186 ± 0.048) L / h and k_10 (0.064 ± 0.016) h_1 and AUC_0-T (1015.29 ± 225.14) mg / · We ~ 1 · L ~ -1, respectively. Conclusion We have successfully used the analytical method for magnesium isoglycyrrhizinate to study its pharmacokinetical properties of health volunteers after iv infusion. The method is found to be simple, accurate, stable and sens itive for application in clinical pharmacokinetics study. The concentration-time plot was fitted to a two-compartment open model with first-order elimination.